Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02128958
Title Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Can-Fite BioPharma
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.